Table 1 Subgroup meta-analysis of HBV and HCV prevalence estimation in Ethiopia

HBV

Study population

Community based

7

8.0 (5.9–10.7)

96.1

<0.001

Blood donors

6

8.4 (5.4–12.7)

95.4

<0.001

HIV co-infected

7

5.2 (3.7–7.4)

75.9

<0.001

Immigrants to Israel

5

11.0 (7.5–15.9)

79.0

0.001

Other groups^a

17

6.9 (5.6–8.5)

87.3

<0.001

Mean age group^b

14–29

8

7.1 (5.6–8.9)

85.3

<0.001

30–45

9

6.7 (5.6–8.1)

39.6

<0.001

Study year

1980–1989

9

9.4 (8.2–10.7)

74.5

<0.001

1990–1999

8

10.7(7.3–15.4)

94.3

<0.001

2000–2009

9

6.3 (5.1–7.9)

76.6

<0.001

2010–2015

16

5.7 (4.9–6.6)

63.4

<0.001

Geographical zone

Central Ethiopia

13

6.4 (5.3–7.6)

81.3

<0.001

Northwest Ethiopia

17

8.2 (6.2–10.8)

93.7

<0.001

Other regions^c

12

7.7 (6.5–9.1)

82.6

<0.001

HCV

Study population

General population^d

16

2.4 (1.6–3.6)

90.4

<0.001

HIV co-infected

8

5.5 (3.8–7.8)

81.8

<0.001

Mean age group

19–29

6

2.3 (0.9–5.8)

96.6

<0.001

30–39

9

3.7 (2.4–5.8)

84.4

<0.001

Study year

1990–1999

3

2.0 (1.5–2.7)

0.00

<0.001

2000–2009

6

2.9 (1.4–5.9)

94.2

<0.001

2010–2015

15

3.7 (2.5–5.4)

88.2

<0.001

Geographical zone

Central Ethiopia

6

3.5(2.0–6.0)

89.0

<0.001

Northwest Ethiopia

10

2.8(1.6–4.7)

87.8

<0.001

Other regions^e

8

3.4(1.7–6.5)

94.8

<0.001